After a heart attack or stroke, routine prescription of anti-platelet drugs to suppress platelet function can be effective, though in some patients they are in-effective leading to additional heart attacks or strokes, or can lead to bleeding complications.
Platelets travel to every tissue and organ in the body. They react to changes in health status, disease progressions, and the on and off-target effects of a wide range of drugs.
This makes platelets the ideal biomarker for assessing efficacy and side effects.
Understand the haemostatic and thrombotic impact of compounds within screening libraries - essential for identifying potential therapeutic candidates or off target effects at an early stage.
Investigate mechanisms of haemostasis and thrombosis and evaluate the effects of novel compounds or therapeutic strategies on platelet activity, thrombosis and bleeding. HaemAnalytica will provide you with in-house platelet expertise.
Registered in England, company number 15921838
Web design by Tribal Systems